Price Comparison

Survodutide

fat loss

7 vendors competing

7 of 7 vendors
Prices for Survodutide by vendor
VendorPrice10mg costUpdatedActions
EZ Peptides9/10
9/10
COA ✓Ships: USVisa · Mastercard
Verification & shipping
9/10
COA ✓Ships: USVisa · Mastercard
$70.20$78.00−10% · code peptideprices10mg package$70.20Checked aug 13, 2026Aug 13, 2026Buy Survodutide from EZ Peptides
Alpha Peptides8/10
8/10
COA ✓Ships: USCredit/debit card
Verification & shipping
8/10
COA ✓Ships: USCredit/debit card
Out of stock
$73.89$82.10−10% · code PEPTIDEPRICES1010mg package$73.89Checked jul 31, 2026Jul 31, 2026Buy Survodutide from Alpha Peptides
Orbitrex Peptides9.5/10
9.5/10
COA ✓Ships: USCredit/debit card
Verification & shipping
9.5/10
COA ✓Ships: USCredit/debit card
$84.99$99.99−15% · code peptideprices10mg package$84.99Checked aug 3, 2026Aug 3, 2026Buy Survodutide from Orbitrex Peptides
Offline Peptides7.5/10
7.5/10
COA ✓Ships: USCredit/debit card
Verification & shipping
7.5/10
COA ✓Ships: USCredit/debit card
$89.0010mg package$89.00Checked jul 28, 2026Jul 28, 2026Buy Survodutide from Offline Peptides
Hydro Research9/10
9/10
COA ✓Ships: USVisa · Mastercard
Verification & shipping
9/10
COA ✓Ships: USVisa · Mastercard
$68.00$80.00−15% · code PEPTIDEP156mg package$136.00Checked jun 5, 2026Jun 5, 2026Buy Survodutide from Hydro Research
Nationwide Peptides6/10
6/10
COA ✓Ships: USCredit/debit card
Verification & shipping
6/10
COA ✓Ships: USCredit/debit card
$163.80$182.00−10% · code peptideprices10mg package$163.80Checked aug 5, 2026Aug 5, 2026Buy Survodutide from Nationwide Peptides

Research details

Survodutide — research data

Half-life~6–7 days. Once weekly SC injection.
Regulatory statusNot FDA-approved (Phase III)
NCAA D1Not listed

Overview

About Survodutide

Mechanism of action

Dual glucagon receptor (GCGR) and GLP-1 receptor agonist; glucagon component increases energy expenditure and hepatic fat oxidation; GLP-1 component suppresses appetite; synergistic weight loss.

Safety profile

Nausea, vomiting, diarrhea, decreased appetite (class effects); potential hepatic enzyme changes; still in trials. · Phase III for MASH/obesity; GI side effects; promising liver/metabolic effects; well-tolerated in trials

Related pages

More on Survodutide

Failed to fetch